Literature DB >> 3082936

Recombinant interleukin 2 and gamma-interferon act synergistically on distinct steps of in vitro terminal human B cell maturation.

A S Fauci.   

Abstract

The effects of recombinant interleukin 2 (IL-2) on the in vitro differentiation of human tonsillar B cells which were not preincubated with Staphylococcus aureus Cowan I or with anti-human IgM were investigated. IL-2 was shown to induce the generation of Ig-containing cells in a dose-dependent fashion from 2.5 to 2,500 U IL-2/ml. Conversely, the quantities of Ig secreted in the culture supernatant were found in the majority of experiments to peak at 25 U/ml. The possible presence, in cultures stimulated with IL-2, of cells that were capable of synthesizing Ig but that did not secrete the Ig they have produced was investigated. Among a number of factors tested, we found that gamma-interferon, which did not trigger in vitro B cell differentiation when used alone, can induce an increased secretion of Ig without noticeable change in the number of Ig-containing cells in cultures stimulated with IL-2. The possibility that gamma-interferon and IL-2 act on subsequent steps of in vitro B cell differentiation is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082936      PMCID: PMC424453          DOI: 10.1172/JCI112418

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Time and dosage dependence of immunoenhancement by murine type II interferon preparations.

Authors:  G Sonnenfeld; A D Mandel; T C Merigan
Journal:  Cell Immunol       Date:  1978-10       Impact factor: 4.868

Review 2.  B cell growth and differentiation factors and mechanism of B cell activation.

Authors:  T Kishimoto; K Yoshizaki; M Kimoto; M Okada; T Kuritani; H Kikutani; K Shimizu; T Nakagawa; N Nakagawa; Y Miki
Journal:  Immunol Rev       Date:  1984-04       Impact factor: 12.988

3.  Gamma-interferon is one of several direct B cell-maturing lymphokines.

Authors:  C L Sidman; J D Marshall; L D Shultz; P W Gray; H M Johnson
Journal:  Nature       Date:  1984 Jun 28-Jul 4       Impact factor: 49.962

4.  Suppression of mitogen-induced peripheral B cell differentiation by soluble Fc gamma receptors released from lymphocytes.

Authors:  C Samarut; J Brochier; W H Fridman; J P Revillard
Journal:  Eur J Immunol       Date:  1980-11       Impact factor: 5.532

Review 5.  Regulation of B-cell growth and differentiation by soluble factors.

Authors:  M Howard; W E Paul
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

6.  Role of gamma-interferon in antibody-producing responses.

Authors:  H J Leibson; M Gefter; A Zlotnik; P Marrack; J W Kappler
Journal:  Nature       Date:  1984 Jun 28-Jul 4       Impact factor: 49.962

7.  Antigen-induced in vitro antibody production in humans: a model for B cell activation and immunoregulation.

Authors:  D J Volkman; H C Lane; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

8.  Interleukin-2 does not induce murine B cells to secrete Ig.

Authors:  E Pure; P C Isakson; V Paetkau; B Caplan; E S Vitetta; P H Krammer
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

9.  Coordinate production by a T cell hybridoma of gamma interferon and three other lymphokine activities: multiple activities of a single lymphokine?

Authors:  A Zlotnik; W K Roberts; A Vasil; E Blumenthal; F Larosa; H J Leibson; R O Endres; S D Graham; J White; J Hill; P Henson; J R Klein; M J Bevan; P Marrack; J W Kappler
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

10.  Expression of Tac antigen on activated normal human B cells.

Authors:  M Tsudo; T Uchiyama; H Uchino
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  8 in total

1.  Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone.

Authors:  I Todd; R Pujol-Borrell; L J Hammond; J M McNally; M Feldmann; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

2.  Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells.

Authors:  J H Kehrl; M Dukovich; G Whalen; P Katz; A S Fauci; W C Greene
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

3.  Transfection of an immunoglobulin kappa gene into mature human B lymphocytes.

Authors:  L T Bich-Thuy; C Queen
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

4.  Interleukin-2 effects on human B cells activated in vivo.

Authors:  T Miyawaki; T Suzuki; J L Butler; M D Cooper
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

Review 5.  The immunomodulatory effects of interferon-gamma on mature B-lymphocyte responses.

Authors:  A Jurado; J Carballido; H Griffel; H K Hochkeppel; G D Wetzel
Journal:  Experientia       Date:  1989-06-15

6.  Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens.

Authors:  G Pastorelli; M G Roncarolo; J L Touraine; G Peronne; P A Tovo; J E de Vries
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

7.  IL-17 Augments B Cell Activation in Ocular Surface Autoimmunity.

Authors:  Brinda Subbarayal; Sunil K Chauhan; Antonio Di Zazzo; Reza Dana
Journal:  J Immunol       Date:  2016-09-21       Impact factor: 5.422

8.  Restricted production of interleukin 4 by activated human T cells.

Authors:  D B Lewis; K S Prickett; A Larsen; K Grabstein; M Weaver; C B Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.